NCT02974725 A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma Status TERMINATED Phase PHASE1
NCT02970981 Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma Status COMPLETED Phase PHASE2
NCT02968680 Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma Status TERMINATED Phase PHASE1
NCT02967692 A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma Status TERMINATED Phase PHASE3
NCT02962947 MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients Status UNKNOWN Phase PHASE2/PHASE3
NCT02949154 Elevated LDH Serum Levels and FDG-PET in Metastatic Melanoma Patients Status COMPLETED Phase N/A
NCT02917473 Comparison of Two Strategies for Counseling Skin Examination and Sun Protection in First-degree Relatives of Patients With Melanoma Status COMPLETED Phase NA
NCT02910557 Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection Status COMPLETED Phase N/A
NCT02909348 Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab Status COMPLETED Phase N/A
NCT02908672 A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma Status COMPLETED Phase PHASE3
NCT02907827 Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence. Status RECRUITING Phase NA
NCT02905266 A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma Status COMPLETED Phase PHASE3
NCT02902822 Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo Status COMPLETED Phase NA
NCT02900248 CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice Status TERMINATED Phase N/A
NCT02897765 A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer Status COMPLETED Phase PHASE1